Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us dr. P.A. (Paul) van der Zwaag
University Medical Center Groningen

dr. P.A. (Paul) van der Zwaag

Clinical geneticist
Profile picture of dr. P.A. (Paul) van der Zwaag
E-mail:
p.a.van.der.zwaag umcg.nl

Publications

Age-related penetrance of phospholamban p.Arg14del cardiomyopathy

Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy

Multigene panel analysis has limited additional value compared to transthyretin gene analysis in Dutch patients with suspected cardiac amyloidosis

Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?: an early follow-up marker?

ECG-only Explainable Deep Learning Algorithm Predicts the Risk for Malignant Ventricular Arrhythmia in Phospholamban Cardiomyopathy

High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients

Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis

Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

[99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients

A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

Press/media

Kwart miljoen opgehaald voor onderzoek naar Friese ziekte: 'Het ontwricht hele families'

Gaspedaal van het hart